BioTime, Inc. (BTX) reported a net loss for the first quarter of $7.7 million or $0.15 per share, compared to a net loss of $5.0 million or $0.10 per share for the year-ago quarter.
Total net revenue for the fell to $431,724 from $631,946 a year ago, due to to lower grant revenue related to the completion of BioTime's research grant from the California Institute for Regenerative Medicine in August 2012, partially offset by subscription and advertising revenues from LifeMap Science's online database GeneCards which LifeMap Sciences began marketing in May 2012.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.